Company / Profit Margin
Vistagen Therapeutics, Inc. Profit Margin History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-4306.8%
FY2023
5-year range
-5066.2% / -820.4%
FY2019-FY2023
Trend
+15.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 6 years, ranging from -21315.0% in FY2014 to -11.2% in FY2011.
Based on SEC 10-K filings.
-4306.8% in FY2023 with a 5-year CAGR of -3486.4%.
Declined from -820.4% to -4306.8% over the past 5 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -3486.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, profit margin increased 15.0% year-over-year.
- Peak profit margin was recorded in FY2011.
- Lowest profit margin in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -4306.8% | +15.0% |
| FY2022 | -5066.2% | - |
| FY2021 | - | - |
| FY2018 | -820.4% | - |
| FY2017 | - | - |
| FY2014 | -21315.0% | -123824.5% |
| FY2012 | -17.2% | -54.3% |
| FY2011 | -11.2% | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026